Citations

Citations to this article as recorded by  

• Optimizing 5-aminosalicylate for moderate ulcerative colitis: expert recommendations from the Asia-Pacific, Middle East, and Africa Inflammatory Bowel Disease Coalition
  Filiz Akyüz, Yoon Kyo An, Jakob Begun, Satimai Aniwan, Huu Hoang Bui, Webber Chan, Chang Hwan Choi, Nazeer Chopdat, Susan J Connor, Devendra Desai, Emma Flanagan, Taku Kobayashi, Allen Yu-Hung Lai, Rupert W Leong, Alex Hwong-Ruey Leow, Wai Keung Leung, Ju
  Intestinal Research.2025; 23(1): 37.     CrossRef
• Understanding Medication Nonadherence in Crohn’s Disease Patients: A Qualitative Evaluation
  Robert E Brady, Jessica K Salwen-Deremer, Natalie C Tunnell, Michael W Winter
  Inflammatory Bowel Diseases.2024; 30(11): 2046.     CrossRef
• Attitudes to medication and effects of IBD nursing service among patients with inflammatory bowel disease in Taiwan
  Chen‐Ta Yang, Tsui‐Chun Hsu, Yang‐Yuan Chen, Siou‐Ping Huang, Hsu‐Heng Yen
  Advances in Digestive Medicine.2024; 11(3): 162.     CrossRef
• COMPLIANCE AND QUALITY OF LIFE OF PATIENTS WITH INFLAMMATORY BOWEL DISEASES
  R.J. JAMOLOVA, D.K. MUKHABBATOV, D.T. RAKHMONOV, S.G. ALI-ZADE
  AVICENNA BULLETIN.2024; 26(1): 76.     CrossRef
• High refill-adherence to adalimumab is associated with low disease activity in patients with inflammatory bowel disease
  Esma H. San, Angelique Egberts, Caroline W. Th. van Dijck - van Boetzelaer, Rachel L. West, Erwin C. Vasbinder
  European Journal of Clinical Pharmacology.2024; 80(7): 1089.     CrossRef
• MMX mesalamine in ulcerative colitis: Major advantages towards classical mesalamine formulations
  Ferdinando D'Amico, Francesca Lusetti, Laurent Peyrin-Biroulet, Silvio Danese
  Digestive and Liver Disease.2024; 56(9): 1425.     CrossRef
• Motivational Interviewing as a Strategy to Improve Adherence in IBD Treatment: An Integrative Review Amidst COVID-19 Disruptions
  Caterina Mercuri, Maria Catone, Vincenzo Bosco, Assunta Guillari, Teresa Rea, Patrizia Doldo, Silvio Simeone
  Healthcare.2024; 12(12): 1210.     CrossRef
• The economic impact of suboptimal treatment and treatment switch among patients with Crohn’s disease treated with a first-line biologic – A US retrospective claims database study
  Patrick Gagnon-Sanschagrin, Myrlene Sanon, Mikhaïl Davidson, Cynthia Willey, Sumesh Kachroo, Timothy Hoops, Dominik Naessens, Annie Guerin, Martin Cloutier
  Journal of Medical Economics.2024; 27(1): 931.     CrossRef
• A Practical Approach to Identify Non-Adherence to Mesalamine Therapy in Inflammatory Bowel Disease
  Filippo Vernia, Giorgia Burrelli Scotti, Raffaele Borghini, Mario Muselli, Stefano Necozione, Giovanni Moretta, Lorenza Scurti, Giuseppe Donato
  Gastroenterology Insights.2024; 15(3): 754.     CrossRef
• Use of Complementary and Alternative Therapies in People with Inflammatory Bowel Disease
  Laura Frank, Kelly Lambert
  International Journal of Environmental Research and Public Health.2024; 21(9): 1140.     CrossRef
• Obstacles to Medication Adherence for Patients with Inflammatory Bowel Disease: A Qualitative Study in East China
  Fen Xu, Jingjing Xing, Mingna Fan, Zhiping Zhu, Yan Chen, Wen Hu, Yunxian Zhou
  Patient Preference and Adherence.2024; Volume 18: 2481.     CrossRef
• A Retrospective Cohort Study of Clinical Features and Treatment Patterns With Ustekinumab in Patients With Crohn Disease Utilizing a Health Care Database in Japan
  Yanfang Liu, Choo Hua Goh, Hong Qiu, Kuan-Chih Huang, Hsingwen Chung, Carine Saadoun
  Annals of Pharmacotherapy.2023; 57(9): 1053.     CrossRef
• Development and implementation of a laboratory monitoring dashboard to reduce treatment gaps in inflammatory bowel disease
  Miranda Kozlicki, Bridget Lynch, Tony Donoho, Patrick Nichols, Autumn D Zuckerman
  American Journal of Health-System Pharmacy.2023; 80(Supplement): S55.     CrossRef
• Efficacy, Safety, Patient Experience, and Tolerability of Risankizumab Administered by On-Body Injector for Moderate to Severe Crohn’s Disease
  Edward V. Loftus, Jenny Griffith, Ezequiel Neimark, Alexandra Song, Kori Wallace, Sujani Nannapaneni, Ji Zhou, Rachel Byrne, Kristina Kligys, Yinuo Pang, Xiaomei Liao, Jasmina Kalabic, Marla Dubinsky
  Advances in Therapy.2023; 40(5): 2311.     CrossRef
• Development and Validation of a Remote Monitoring Tool for Assessment of Mild, Moderate, and Severe Infections in Inflammatory Bowel Disease
  Ashkan Rezazadeh Ardabili, Dirk van Esser, Dion Wintjens, Mia Cilissen, Debbie Deben, Zlatan Mujagic, Fritzi Russ, Laurents Stassen, Adriaan A Van Bodegraven, Dennis Wong, Bjorn Winkens, Daisy Jonkers, Mariëlle Romberg-Camps, Marie J Pierik
  Journal of Crohn's and Colitis.2023; 17(7): 1079.     CrossRef
• Factors contributing to flares of ulcerative colitis in North India- a case-control study
  Vishavdeep Singh Rana, Gaurav Mahajan, Amol N. Patil, Anupam K. Singh, Vaneet Jearth, Aravind Sekar, Harjeet Singh, Atul Saroch, Usha Dutta, Vishal Sharma
  BMC Gastroenterology.2023;[Epub]     CrossRef
• An education‐based telehealth group improves the management and clinical outcomes of patients with inflammatory bowel disease in China (THEIM study)
  Jian Kang, Juan Su, Jing Wang, Haixia Ren, Anning Yin, Jiao Li, Qian Zhou, Yang Wang, Peng Zhu, Liping Zou, Wei Wang, Zhishun Tang, Weiguo Dong, Yijuan Ding, Ping An
  United European Gastroenterology Journal.2023; 11(10): 960.     CrossRef
• Delaying an infliximab infusion by more than 3 days is associated with a significant reduction in trough levels but not with clinical worsening
  Zohar Ben-Shatach, Tomer Ziv-Baran, Ella Fudim, Miri Yavzori, Orit Picard, Asaf Levartovsky, Limor Selinger, Batia Weiss, Uri Kopylov, Rami Eliakim, Bella Ungar
  Therapeutic Advances in Gastroenterology.2022;[Epub]     CrossRef
• Medication Adherence and Its Influencing Factors Among Inflammatory Bowel Disease Patients in China
  Fen Xu, Juping Tang, Zhiping Zhu, Yan Chen, Wen Hu, Sha Lu, Yunxian Zhou, Ding Lin
  International Journal of General Medicine.2022; Volume 15: 4141.     CrossRef
• Indicators of Suboptimal Treatment and Associated Healthcare Costs Among Patients With Crohn’s Disease Initiated on Biologic or Conventional Agents
  Dominic Pilon, Zhijie Ding, Erik Muser, Ameur M Manceur, Maude Vermette-Laforme, Marie-Hélène Lafeuille, Patrick Lefebvre
  Crohn's & Colitis 360.2022;[Epub]     CrossRef
• Medication adherence in women with IBD of childbearing age likely associated with disease knowledge
  Robyn Laube, Christian Selinger, Rupert W. Leong
  Therapeutic Advances in Gastroenterology.2022;[Epub]     CrossRef
• Utility of the MARS-5 in Assessing Medication Adherence in IBD
  James K Stone, Leigh Anne Shafer, Lesley A Graff, Lisa Lix, Kelcie Witges, Laura E Targownik, Clove Haviva, Kathryn Sexton, Charles N Bernstein
  Inflammatory Bowel Diseases.2021; 27(3): 317.     CrossRef
• Non-adherence to Medications in Pregnant Ulcerative Colitis Patients Contributes to Disease Flares and Adverse Pregnancy Outcomes
  Chikako Watanabe, Masakazu Nagahori, Toshimitsu Fujii, Kaoru Yokoyama, Naoki Yoshimura, Taku Kobayashi, Hirokazu Yamagami, Kazuya Kitamura, Kagaya Takashi, Shiro Nakamura, Makoto Naganuma, Shunji Ishihara, Motohiro Esaki, Maria Yonezawa, Reiko Kunisaki, A
  Digestive Diseases and Sciences.2021; 66(2): 577.     CrossRef
• Selected psychological predictors of medication adherence in the older adults with chronic diseases
  Magdalena Gruszczyńska, Julia Wyszomirska, Anna Daniel‐Sielańczyk, Monika Bąk‐Sosnowska
  Nursing Open.2021; 8(1): 317.     CrossRef
• Impacto de la pandemia covid-19 en la adherencia al tratamiento en pacientes con enfermedad inflamatoria intestinal: experiencia de un centro terciario en Chile
  Rodrigo Quera, Daniela Simian, Lilian Flores, Patricio Ibáñez, Carolina Figueroa
  Gastroenterología y Hepatología.2021; 44(9): 654.     CrossRef
• Adherence to Subcutaneous Biological Therapies in Patients with Inflammatory Rheumatic Diseases and Inflammatory Bowel Disease: A Systematic Review
  Juan C Nieto, Claudia Arajol, Loreto Carmona, Carlos Marras, Luis Cea-Calvo
  Immunotherapy.2021; 13(5): 433.     CrossRef
• Researching Interventions to Improve Medication Adherence in Ulcerative Colitis Patients
  Mila Palma Pacheco, Flora Maria Lorenzo Fortes, Raquel Rocha dos Santos, Genoile Oliveira Santana Silva
  Journal of Coloproctology.2021; 41(01): 096.     CrossRef
• Persistence as a Robust Indicator of Medication Adherence-Related Quality and Performance
  Enrica Menditto, Caitriona Cahir, Sara Malo, Isabel Aguilar-Palacio, Marta Almada, Elisio Costa, Anna Giardini, María Gil Peinado, Mireia Massot Mesquida, Sara Mucherino, Valentina Orlando, Carlos Luis Parra-Calderón, Enrique Pepiol Salom, Przemyslaw Kard
  International Journal of Environmental Research and Public Health.2021; 18(9): 4872.     CrossRef
• Effect of point‐of‐care gastrointestinal ultrasound on decision‐making and management in inflammatory bowel disease
  Antony B. Friedman, Anil Asthana, Simon R. Knowles, Aphra Robbins, Peter R. Gibson
  Alimentary Pharmacology & Therapeutics.2021; 54(5): 652.     CrossRef
• Impact of the COVID-19 pandemic on treatment adherence in patients with inflammatory bowel disease: Experience of a tertiary hospital in Chile
  Rodrigo Quera, Daniela Simian, Lilian Flores, Patricio Ibáñez, Carolina Figueroa
  Gastroenterología y Hepatología (English Edition).2021; 44(9): 654.     CrossRef
• Adherence to treatment in patients with inflammatory bowel disease
  K. A. Andreev, A. V. Gorbenko, Yu. P. Skirdenko, N. A. Nikolaev, M. A. Livzan, G. R. Bikbavova, M. M. Fedorin
  Bulletin of Siberian Medicine.2021; 20(3): 120.     CrossRef
• Treatment Adherence in Inflammatory Bowel Disease Patients from Argentina: A Multicenter Study
  Juan Lasa, Gustavo Correa, Claudia Fuxman, Laura Garbi, Maria Eugenia Linares, Pablo Lubrano, Astrid Rausch, Martin Toro, Martin Yantorno, Ignacio Zubiaurre, Laurent Peyrin-Biroulet, Pablo Olivera
  Gastroenterology Research and Practice.2020; 2020: 1.     CrossRef
• Knowledge of disease and self‐management of adolescents with inflammatory bowel diseases
  Alex Krauthammer, Tal Harel, Noam Zevit, Dror S. Shouval, Raanan Shamir, Batia Weiss
  Acta Paediatrica.2020; 109(10): 2119.     CrossRef
• The burden of cost in inflammatory bowel disease: a medical economic perspective
  Jonathan A. Beard, Benjamin H. Click
  Current Opinion in Gastroenterology.2020; 36(4): 310.     CrossRef
• İnflamatuar Bağırsak Hastalıkları Olan Bireylerde İlaç Uyumu ve Yaşam Kalitesi
  Nazli ÖZTÜRK, Yasemin YILDIRIM
  Bandırma Onyedi Eylül Üniversitesi Sağlık Bilimleri ve Araştırmaları Dergisi.2020; 2(3): 192.     CrossRef
• Unmet Medical Needs in the Management of Ulcerative Colitis: Results of an Italian Delphi Consensus
  Marco Daperno, Alessandro Armuzzi, Silvio Danese, Walter Fries, Giuseppina Liguori, Ambrogio Orlando, Claudio Papi, Mariabeatrice Principi, Fernando Rizzello, Angelo Viscido, Paolo Gionchetti
  Gastroenterology Research and Practice.2019; 2019: 1.     CrossRef
• The Development of a Screening Tool to Identify and Classify Nonadherence in Inflammatory Bowel Disease
  Aria Zand, Audrey Nguyen, Zack Stokes, Welmoed van Deen, Courtney Reynolds, Magdalena Dimitrova, Ariela Khandadash, Miriam Dvorsky, Jenny Sauk, Eric Esrailian, Daniel Hommes
  Crohn's & Colitis 360.2019;[Epub]     CrossRef
• Adherence to therapy of patients with inflammatory bowel diseases
  A I Parfenov, A V Kagramanova, A F Babayan, O V Knyazev
  Terapevticheskii arkhiv.2018; 90(12): 4.     CrossRef

Inflammatory bowel disease (IBD) is a chronic idiopathic inflammatory condition with intestinal and extraintestinal manifestations. Medications are the cornerstone of treatment of IBD. However, patients often adhere to medication poorly. Adherence to medications is defined as the process by which patients take their medications as prescribed. Treatment non-adherence is a common problem among chronic diseases, averaging 50% in developed countries and is even poorer in developing countries. In this review, we will examine the adherence data in IBD which vary greatly depending on the study population, route of administration, and methods of adherence measurement used. We will also discuss the adverse clinical outcomes related to non-adherence to medical treatment including increased disease activity, flares, loss of response to anti-tumor necrosis factor therapy, and so forth. There are many methods to measure medication adherence namely direct and indirect methods, each with their advantages and drawbacks. Finally, we will explore different intervention strategies to improve adherence to medications.

Citations

Citations to this article as recorded by  

• Satisfaction With and Adherence to Off-Label Corticosteroids in Adolescents and Adults With Eosinophilic Esophagitis
  Benjamin D. Gold, Bridgett Goodwin, Kimberly Davis, Carolyn Sweeney, Ryan Ziemiecki, Jeanne Jiang, Tao Fan, Mena Boules, Szu-Ta Chen, David A. Katzka
  Journal of Clinical Gastroenterology.2025; 59(2): 138.     CrossRef
• Interprofessional approach to personalized medication management and therapy optimization in IBD care
  Daniel Fleischmann, Benedicta Binder, Muriel Huss, Tanja Elger, Claudia Wolf, Johanna Loibl, Hauke Christian Tews, Arne Kandulski, Stephan Schmid, Martina Müller, Alexander Kratzer
  Frontiers in Medicine.2025;[Epub]     CrossRef
• Medication Non-Adherence in Inflammatory Bowel Disease: A Systematic Review Identifying Risk Factors and Opportunities for Intervention
  Kathryn King, Wladyslawa Czuber-Dochan, Trudie Chalder, Christine Norton
  Pharmacy.2025; 13(1): 21.     CrossRef
• Differences between healthcare practitioners' and patients' perceptions of IBD and its causative factors
  Alexa Duff, Patrick Dawson, Polychronic Pavilidis, Joel Mawdsley
  Gastrointestinal Nursing.2025; 23(1): 21.     CrossRef
• Practical Application of Evidence-Based Dietary Therapy in Inflammatory Bowel Disease: The DELECTABLE Program
  Gina Trakman, Erin Russell, Amy Hamilton, Amy Wilson-O’Brien, Emily Thompson, Natalie Simmance, Ola Niewiadomski, Michael Kamm
  Nutrients.2025; 17(9): 1592.     CrossRef
• Despite Increased Disease Activity, Women who Attended a Dedicated Inflammatory Bowel Disease and Pregnancy Clinic Had Infants With Higher Apgar Scores: A Population-Based Study
  Sangmin Lee, Cynthia H Seow, Kara Nerenberg, Stefania Bertazzon, Yvette Leung, Vivian Huang, Tara Whitten, Stephanie Coward, Remo Panaccione, Gilaad G Kaplan, Amy Metcalfe
  Inflammatory Bowel Diseases.2024; 30(7): 1071.     CrossRef
• Knowledge in Inflammatory Bowel Disease: Translation to Portuguese, Validation, and Clinical Application of the IBD-KNOW Questionnaire
  Cristiana Sequeira, Mariana Coelho, Inês Costa Santos, Sara Ramos Lopes, Cristina Teixeira, João Mangualde, Isabelle Cremers, Ana Paula Oliveira
  GE - Portuguese Journal of Gastroenterology.2024; 31(4): 246.     CrossRef
• Understanding Medication Nonadherence in Crohn’s Disease Patients: A Qualitative Evaluation
  Robert E Brady, Jessica K Salwen-Deremer, Natalie C Tunnell, Michael W Winter
  Inflammatory Bowel Diseases.2024; 30(11): 2046.     CrossRef
• Effectiveness of Single-Tablet Combination Therapy in Improving Adherence and Persistence and the Relation to Clinical and Economic Outcomes
  Carly J. Paoli, Jörg Linder, Khushboo Gurjar, Deepika Thakur, Julie Wyckmans, Stacy Grieve
  Journal of Health Economics and Outcomes Research.2024;[Epub]     CrossRef
• Effectiveness of Single-Tablet Combination Therapy in Improving Adherence and Persistence and the Relation to Clinical and Economic Outcomes
  Carly Paoli, Jörg Linder, Khushboo Gurjar, Deepika Thakur, Julie Wyckmans, Stacy Grieve
  Journal of Health Economics and Outcomes Research.2024; : 8.     CrossRef
• Inflammatory bowel disease (IBD) patients with impaired quality of life on biologic therapy benefit from the support of an IBD nurse specialist: Results of a randomised controlled trial in Germany (IBDBIO‐ASSIST study)
  Bernd Bokemeyer, Sandra Plachta‐Danielzik, Isa Maria Steiner, Daniela Pohlschneider, Eugen Urzica, Petra Hartmann, Jennifer Zemke, Ulrich Tappe, Stefan Schreiber, Nadine Steinkat, Jana Langbrandtner, Angelika Hüppe, Tom Stargardt
  Alimentary Pharmacology & Therapeutics.2024; 59(9): 1082.     CrossRef
• How can we improve the carbon footprint of IBD clinical care?
  Isabel Carbery, Gauraang Bhatnagar, Rachel Cooney, Christian Selinger
  Frontline Gastroenterology.2024; 15(e1): e55.     CrossRef
• Unmet needs of drugs for irritable bowel syndrome and inflammatory bowel diseases: interest of vagus nerve stimulation and hypnosis
  Bruno Bonaz
  Inflammopharmacology.2024; 32(2): 1005.     CrossRef
• High refill-adherence to adalimumab is associated with low disease activity in patients with inflammatory bowel disease
  Esma H. San, Angelique Egberts, Caroline W. Th. van Dijck - van Boetzelaer, Rachel L. West, Erwin C. Vasbinder
  European Journal of Clinical Pharmacology.2024; 80(7): 1089.     CrossRef
• Improving Medication Adherence Levels in Inflammatory Bowel Disease (IBD) Patients: A Narrative Evidence-Based Review
  Obreniokibo Amiesimaka, Kristina Aluzaite, Rhiannon Braund, Michael Schultz
  Patient Preference and Adherence.2024; Volume 18: 905.     CrossRef
• How the Western Diet Thwarts the Epigenetic Efforts of Gut Microbes in Ulcerative Colitis and Its Association with Colorectal Cancer
  Avisek Majumder, Shabana Bano
  Biomolecules.2024; 14(6): 633.     CrossRef
• Exploring the foundations of a digital health information service for patients with inflammatory bowel disease: a mixed method study in Gravitate-Health
  Sigurd Maurud, Lene Lunde, Anne Moen, Randi Opheim
  BMC Gastroenterology.2024;[Epub]     CrossRef
• Influence of multidisciplinary team care with abundant nurse staffing on patient-reported outcomes among patients with inflammatory bowel disease in clinical remission
  Makoto Tanaka, Aki Kawakami, Kayoko Sakagami, Tomoko Terai, Hiroaki ito
  Health and Quality of Life Outcomes.2024;[Epub]     CrossRef
• Motivational Interviewing as a Strategy to Improve Adherence in IBD Treatment: An Integrative Review Amidst COVID-19 Disruptions
  Caterina Mercuri, Maria Catone, Vincenzo Bosco, Assunta Guillari, Teresa Rea, Patrizia Doldo, Silvio Simeone
  Healthcare.2024; 12(12): 1210.     CrossRef
• Effect of Curcumin Plus Piperine on Redox Imbalance, Fecal Calprotectin and Cytokine Levels in Inflammatory Bowel Disease Patients: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
  Amylly Sanuelly da Paz Martins, Orlando Roberto Pimentel de Araújo, Amanda da Silva Gomes, Fernanda Lívia Cavalcante Araujo, José Oliveira Junior, Joice Kelly Gomes de Vasconcelos, José Israel Rodrigues Junior, Islany Thaissa Cerqueira, Manoel Álvaro de F
  Pharmaceuticals.2024; 17(7): 849.     CrossRef
• What aspects do we overlook in the rehabilitation of patients with inflammatory bowel disease?
  Benil Nesli Ata, Sibel Eyigor
  World Journal of Gastroenterology.2024; 30(27): 3268.     CrossRef
• Fournier's Gangrene Associated With Untreated Crohn’s Disease in a Male Patient: A Case Report and Review of the Literature
  Nicos Kritharides, Marios Fouzas, Afroditi Stoupa, Spyridoula Sakkoula, Loukia Prounia - Alexopoulou, Georgios Rallis, Aikaterini Leventi
  Cureus.2024;[Epub]     CrossRef
• Enhancing self-management of patients with inflammatory bowel disease: the role of autonomy support in health goal pursuit
  Barbara Horvát, Kata Orbán, Anett Dávid, Viola Sallay, Beatrix Rafael, Sanela Njers, Tamás Molnár, Márta Csabai, Georgina Csordás, Tamás Martos
  Therapeutic Advances in Gastroenterology.2024;[Epub]     CrossRef
• Adherence to infliximab treatment in patients with immune-mediated inflammatory diseases from a referral center in Brazil: a cohort study
  Priscila Moreira Lauton, Fernanda Silva Pereira, Livia Brito Oliveira, Alline Mikaelle Nunes Wildemberg Brauer, Lucia de Araújo Costa Beisl Noblat, Genoile Oliveira Santana, Pablo Moura Santos
  BMC Gastroenterology.2024;[Epub]     CrossRef
• Review article: Measuring disease severity in inflammatory bowel disease – Beyond treat to target
  Akhilesh Swaminathan, Andrew S. Day, Miles P. Sparrow, Laurent Peyrin‐Biroulet, Corey A. Siegel, Richard B. Gearry
  Alimentary Pharmacology & Therapeutics.2024; 60(9): 1176.     CrossRef
• Refractory Crohn’s Disease: Perspectives, Unmet Needs and Innovations
  Luisa Bertin, Martina Crepaldi, Miriana Zanconato, Greta Lorenzon, Daria Maniero, Caterina De Barba, Erica Bonazzi, Sonia Facchin, Marco Scarpa, Cesare Ruffolo, Imerio Angriman, Andrea Buda, Fabiana Zingone, Edoardo Vincenzo Savarino, Brigida Barberio
  Clinical and Experimental Gastroenterology.2024; Volume 17: 261.     CrossRef
• Diagnostic and Therapeutic Microbial Circuit with Application to Intestinal Inflammation
  Liana N. Merk, Andrey S. Shur, Smrutiti Jena, Javier Munoz, Douglas K. Brubaker, Richard M. Murray, Leopold N. Green
  ACS Synthetic Biology.2024; 13(12): 3885.     CrossRef
• Obstacles to Medication Adherence for Patients with Inflammatory Bowel Disease: A Qualitative Study in East China
  Fen Xu, Jingjing Xing, Mingna Fan, Zhiping Zhu, Yan Chen, Wen Hu, Yunxian Zhou
  Patient Preference and Adherence.2024; Volume 18: 2481.     CrossRef
• The role of clinical pharmacists in chronic disease management: Review
  Mohammed Ziad Aldaajani, ‏Abdulmajeed Muhayya Almutairi, Eissa Homuday Almuteriee, ‏Abdullah Saleh Almorshed, ‏Abdullah Abdulrahman Alrbian, ‏Majed Suliman Alwalie, ‏Faleh Mohammed Al Dawsar, Manar Ibrahem Alwehaibi, Mohammed Mesfer Musaed Al Khathami, No
  International journal of health sciences.2024; 8(S1): 1766.     CrossRef
• Real-World Effectiveness and Safety of Carotegrast Methyl in Japanese Patients with Moderately Active Ulcerative Colitis
  Toshihide Ohmori
  Inflammatory Intestinal Diseases.2024; 9(1): 271.     CrossRef
• Prediction of the Short-Term Effectiveness of Ustekinumab in Patients with Moderate to Severe Crohn’s Disease
  Tao Su, Ling Liu, Fan Meng, Hongzhen Wu, Tao Liu, Jun Deng, Xiang Peng, Min Zhi, Jiayin Yao
  Journal of Inflammation Research.2024; Volume 17: 9181.     CrossRef
• Factors influencing medication adherence among patients with idiopathic inflammatory bowel disease in Greece and Cyprus: a cross-sectional study
  Anastasia N. Nicolaou, Maria Saridi, Evangelos C. Fradelos, Ioannis P. Kaimakliotis, Konstantinos Giannakou, Konstantinos H. Katsanos, Stavroula A. Apostolidou
  Polski Merkuriusz Lekarski.2024; 52(5): 489.     CrossRef
• Psychological Factors Associated With Adherence to Oral Treatment in Ulcerative Colitis
  Sonya S Dasharathy, Millie D Long, Jeffrey M Lackner, Dana Ben-Ami Shor, Liu Yang, Nir Bar, Christina Ha, Guy A Weiss
  Inflammatory Bowel Diseases.2023; 29(1): 97.     CrossRef
• Development of an Inflammatory Bowel Disease-Specific Medication Adherence Instrument and Reasons for Non-adherence
  Erica J. Brenner, Millie D. Long, Michael D. Kappelman, Xian Zhang, Robert S. Sandler, Edward L. Barnes
  Digestive Diseases and Sciences.2023; 68(1): 58.     CrossRef
• Impact of a pharmacist‐led thiopurine monitoring service in outpatients with inflammatory bowel disease
  Sheridan E. Rodda, Karina J. Fildes, Edward Shelton, Rimma Goldberg, Gregory T. Moore
  Internal Medicine Journal.2023; 53(5): 779.     CrossRef
• Modulating the Microbiome for Crohn’s Disease Treatment
  Rachael Gowen, Ahmed Gamal, Luca Di Martino, Thomas S. McCormick, Mahmoud A. Ghannoum
  Gastroenterology.2023; 164(5): 828.     CrossRef
• The level of adherence to best-practice guidelines by interprofessional teams with and without acute care nurse practitioners in cardiac surgery: A study protocol
  Li-Anne Audet, Mélanie Lavoie-Tremblay, Éric Tchouaket, Kelley Kilpatrick, Robert Jeenchen Chen
  PLOS ONE.2023; 18(3): e0282467.     CrossRef
• Identification of inadequate responders to advanced therapy among commercially-insured adult patients with Crohn’s disease and ulcerative colitis in the United States
  Theresa Hunter Gibble, April N. Naegeli, Michael Grabner, Keith Isenberg, Mingyang Shan, Chia-Chen Teng, Jeffrey R. Curtis
  BMC Gastroenterology.2023;[Epub]     CrossRef
• Update on the role of upadacitinib in the treatment of adults with moderately to severely active ulcerative colitis
  Kenneth Ernest-Suarez, Remo Panaccione
  Therapeutic Advances in Gastroenterology.2023;[Epub]     CrossRef
• Efficacy, Safety, Patient Experience, and Tolerability of Risankizumab Administered by On-Body Injector for Moderate to Severe Crohn’s Disease
  Edward V. Loftus, Jenny Griffith, Ezequiel Neimark, Alexandra Song, Kori Wallace, Sujani Nannapaneni, Ji Zhou, Rachel Byrne, Kristina Kligys, Yinuo Pang, Xiaomei Liao, Jasmina Kalabic, Marla Dubinsky
  Advances in Therapy.2023; 40(5): 2311.     CrossRef
• Overcoming barriers to patient adherence: the case for developing innovative drug delivery systems
  Tsvetelina H. Baryakova, Brett H. Pogostin, Robert Langer, Kevin J. McHugh
  Nature Reviews Drug Discovery.2023; 22(5): 387.     CrossRef
• Selective JAK1 inhibitors for the treatment of inflammatory bowel disease
  Ole Haagen Nielsen, Theresa Louise Boye, John Gubatan, Deepavali Chakravarti, James B. Jaquith, Eric C. LaCasse
  Pharmacology & Therapeutics.2023; 245: 108402.     CrossRef
• Health Communication Research Informs Inflammatory Bowel Disease Practice and Research: A Narrative Review
  Neda Karimi, Alison Rotha Moore, Annabelle Lukin, Susan J Connor
  Crohn's & Colitis 360.2023;[Epub]     CrossRef
• Medication Adherence Rates in Adolescents With Eosinophilic Esophagitis Are Low and Are Associated With Health Habits
  Pooja Mehta, Zhaoxing Pan, Wenru Zhou, Bethany M. Kwan, Glenn T. Furuta
  Journal of Pediatric Gastroenterology & Nutrition.2023; 77(4): 532.     CrossRef
• “It's just like putting your socks on”: patients' perspectives on inflammatory bowel disease medication adherence
  Obreniokibo Ibifubara Amiesimaka, Kristina Aluzaite, Rhiannon Braund, Michael Schultz
  Exploratory Research in Clinical and Social Pharmacy.2023; 12: 100385.     CrossRef
• Non-invasive vagus nerve stimulation: the future of inflammatory bowel disease treatment?
  Bruno Bonaz
  Bioelectronic Medicine.2023;[Epub]     CrossRef
• What Do We Know about Medication Adherence Interventions in Inflammatory Bowel Disease, Multiple Sclerosis and Rheumatoid Arthritis? A Scoping Review of Randomised Controlled Trials
  Kathryn King, Serena McGuinness, Natalie Watson, Christine Norton, Trudie Chalder, Wladyslawa Czuber-Dochan
  Patient Preference and Adherence.2023; Volume 17: 3265.     CrossRef
• Impact of an intervention program on drug adherence in patients with ulcerative colitis: Randomized clinical trial
  Mila Pacheco, Pedro Sá, Gláucia Santos, Ney Boa-Sorte, Kilma Domingues, Larissa Assis, Marina Silva, Ana Oliveira, Daniel Santos, Jamile Ferreira, Rosemeire Fernandes, Flora Fortes, Raquel Rocha, Genoile Santana, Wan-Long Chuang
  PLOS ONE.2023; 18(12): e0295832.     CrossRef
• Interventions to improve medication adherence in inflammatory bowel disease: A systematic review
  Shrey Gohil, Zahra Majd, Jared C. Sheneman, Susan M. Abughosh
  Patient Education and Counseling.2022; 105(7): 1731.     CrossRef
• Assessing the repercussions of COVID-19 pandemic on symptoms, disease management, and emotional well-being in patients with inflammatory bowel disease: a multi-site survey study
  Mohammed El-Dallal, Ariana Saroufim, Hannah Systrom, Sarah Ballou, Adel Farhoud, Ravi Teja Pasam, Salini Samyuktha Gadupudi, Karim Osman, Khadija Chaudrey, Adam Cheifetz, Joseph D. Feuerstein
  Scandinavian Journal of Gastroenterology.2022; 57(4): 406.     CrossRef
• Health Confidence Is Associated With Disease Outcomes and Health Care Utilization in Inflammatory Bowel Disease: A Nationwide Cross-sectional Study
  Chung Sang Tse, Corey A Siegel, S Alandra Weaver, Brant J Oliver, Catherine Bresee, Welmoed K van Deen, Gil Y Melmed
  Inflammatory Bowel Diseases.2022; 28(10): 1565.     CrossRef
• Impact of PEGylation on an antibody-loaded nanoparticle-based drug delivery system for the treatment of inflammatory bowel disease
  Neha Shrestha, Yining Xu, Julien R.C. Prévost, Fiona McCartney, David Brayden, Raphaël Frédérick, Ana Beloqui, Véronique Préat
  Acta Biomaterialia.2022; 140: 561.     CrossRef
• Stopping Anti-TNF in Crohn’s Disease Remitters: Pros and Cons: The Pros
  Edouard Louis
  Inflammatory Intestinal Diseases.2022; 7(1): 64.     CrossRef
• Factors associated with poor compliance amongst hospitalized, predominantly adolescent pediatric Crohn’s disease patients
  Nathaniel A. Cohen, Dejan M. Micic, Atsushi Sakuraba
  Annals of Medicine.2022; 54(1): 886.     CrossRef
• Proactive infliximab optimisation using a pharmacokinetic dashboard versus standard of care in patients with Crohn’s disease: study protocol for a randomised, controlled, multicentre, open-label study (the OPTIMIZE trial)
  Konstantinos Papamichael, Vipul Jairath, Guangyong Zou, Benjamin Cohen, Timothy Ritter, Bruce Sands, Corey Siegel, John Valentine, Michelle Smith, Niels Vande Casteele, Marla Dubinsky, Adam Cheifetz
  BMJ Open.2022; 12(4): e057656.     CrossRef
• Medication Adherence and Its Influencing Factors Among Inflammatory Bowel Disease Patients in China
  Fen Xu, Juping Tang, Zhiping Zhu, Yan Chen, Wen Hu, Sha Lu, Yunxian Zhou, Ding Lin
  International Journal of General Medicine.2022; Volume 15: 4141.     CrossRef
• Treatment persistence and maintenance dose titration among ulcerative colitis patients on biologics: a pooled study of three United States claim databases
  Janvi Sah, Amanda Teeple, Erik Muser, Cynthia Gutierrez, Themistocles Dassopoulos
  Current Medical Research and Opinion.2022; 38(7): 1093.     CrossRef
• Psychological Effects and Medication Adherence among Korean Patients with Inflammatory Bowel Disease during the Coronavirus Disease 2019 Pandemic: A Single-Center Survey
  Ji Eun Ryu, Sung-Goo Kang, Sung Hoon Jung, Shin Hee Lee, Sang-Bum Kang
  Journal of Clinical Medicine.2022; 11(11): 3034.     CrossRef
• Factors influencing poor medication adherence amongst patients with chronic disease in low-and-middle-income countries: A systematic scoping review
  Gloria Dunisani Chauke, Olivia Nakwafila, Buyisile Chibi, Benn Sartorius, Tivani Mashamba-Thompson
  Heliyon.2022; 8(6): e09716.     CrossRef
• Rational Design of Self-Emulsifying Pellet Formulation of Thymol: Technology Development Guided by Molecular-Level Structure Characterization and Ex Vivo Testing
  Jan Macku, Katerina Kubova, Martina Urbanova, Jan Muselik, Ales Franc, Gabriela Koutna, Miroslava Pavelkova, David Vetchy, Josef Masek, Eliska Maskova, Jiri Brus
  Pharmaceutics.2022; 14(8): 1545.     CrossRef
• Poor Adherence to Medical and Dietary Treatments in Adult Patients With Eosinophilic Esophagitis
  Maria L. Haasnoot, Salma Safi, Albert J. Bredenoord
  American Journal of Gastroenterology.2022; 117(9): 1412.     CrossRef
• Improvement in Medication Adherence after Pharmacist Intervention Is Associated with Favorable Clinical Outcomes in Patients with Ulcerative Colitis
  Jae Song Kim, Min Jung Geum, Eun Sun Son, Yun Mi Yu, Jae Hee Cheon, Kyeng Hee Kwon
  Gut and Liver.2022; 16(5): 736.     CrossRef
• Qualitative Interviews to Support Development and Cognitive Debriefing of the Adelphi Adherence Questionnaire (ADAQ©): A Patient-Reported Measure of Medication Adherence Developed for Use in a Range of Diseases, Treatment Modalities, and Countries
  Sarah Bentley, Lucy Morgan, Elizabeth Exall, Rob Arbuckle, Rebecca C Rossom, Nicholas Roche, Kamlesh Khunti, Victoria Higgins, James Piercy
  Patient Preference and Adherence.2022; Volume 16: 2579.     CrossRef
• Electrical neuromodulation therapy for inflammatory bowel disease
  Farah Yasmin, Abdul Moiz Sahito, Syeda Lamiya Mir, Govinda Khatri, Somina Shaikh, Ambresha Gul, Syed Adeel Hassan, Thoyaja Koritala, Salim Surani
  World Journal of Gastrointestinal Pathophysiology.2022; 13(5): 128.     CrossRef
• Mobile Apps for the Management of Gastrointestinal Diseases: Systematic Search and Evaluation Within App Stores
  Eva-Maria Messner, Niklas Sturm, Yannik Terhorst, Lasse B Sander, Dana Schultchen, Alexandra Portenhauser, Simone Schmidbaur, Michael Stach, Jochen Klaus, Harald Baumeister, Benjamin M Walter
  Journal of Medical Internet Research.2022; 24(10): e37497.     CrossRef
• A Novel Remote Patient and Medication Monitoring Solution to Improve Adherence and Persistence With Inflammatory Bowel Disease Therapy (ASSIST Study): Protocol for a Randomized Controlled Trial
  Jordan Axelrad, Millie Long, Sara Horst, Anita Afzali, Tamar Sapir, Kristina Fajardo, Kara De Felice, Robert Sandler, Raymond Cross
  JMIR Research Protocols.2022; 11(12): e40382.     CrossRef
• Medication adherence in women with IBD of childbearing age likely associated with disease knowledge
  Robyn Laube, Christian Selinger, Rupert W. Leong
  Therapeutic Advances in Gastroenterology.2022;[Epub]     CrossRef
• Racial or ethnic differences on treatment adherence and persistence among patients with inflammatory bowel diseases initiated with biologic therapies
  Qian Cai, Zhijie Ding, Alex Z. Fu, Aarti A. Patel
  BMC Gastroenterology.2022;[Epub]     CrossRef
• Adherence to glaucoma medication, illness perceptions, and beliefs about glaucoma: Attitudinal perspectives among Turkish population
  Soner Guven, Mehmet Talay Koylu, Tarkan Mumcuoglu
  European Journal of Ophthalmology.2021; 31(2): 469.     CrossRef
• Utility of the MARS-5 in Assessing Medication Adherence in IBD
  James K Stone, Leigh Anne Shafer, Lesley A Graff, Lisa Lix, Kelcie Witges, Laura E Targownik, Clove Haviva, Kathryn Sexton, Charles N Bernstein
  Inflammatory Bowel Diseases.2021; 27(3): 317.     CrossRef
• Curcumin and inflammatory bowel diseases: From in vitro studies to clinical trials
  Farzaneh Fallahi, Sarina Borran, Milad Ashrafizadeh, Ali Zarrabi, Mohammad Hossein Pourhanifeh, Mahmood Khaksary Mahabady, Amirhossein Sahebkar, Hamed Mirzaei
  Molecular Immunology.2021; 130: 20.     CrossRef
• Infection risk in sarcoidosis patients treated with methotrexate compared to azathioprine: A retrospective ‘target trial’ emulated with Swedish real‐world data
  Marios Rossides, Susanna Kullberg, Daniela Di Giuseppe, Anders Eklund, Johan Grunewald, Johan Askling, Elizabeth V. Arkema
  Respirology.2021; 26(5): 452.     CrossRef
• Adherence to Subcutaneous Biological Therapies in Patients with Inflammatory Rheumatic Diseases and Inflammatory Bowel Disease: A Systematic Review
  Juan C Nieto, Claudia Arajol, Loreto Carmona, Carlos Marras, Luis Cea-Calvo
  Immunotherapy.2021; 13(5): 433.     CrossRef
• Digital Medication Adherence Support: Could Healthcare Providers Recommend Mobile Health Apps?
  Claudine Backes, Carla Moyano, Camille Rimaud, Christine Bienvenu, Marie P. Schneider
  Frontiers in Medical Technology.2021;[Epub]     CrossRef
• Therapeutic Potential of Vagus Nerve Stimulation for Inflammatory Bowel Diseases
  Bruno Bonaz, Valérie Sinniger, Sonia Pellissier
  Frontiers in Neuroscience.2021;[Epub]     CrossRef
• Researching Interventions to Improve Medication Adherence in Ulcerative Colitis Patients
  Mila Palma Pacheco, Flora Maria Lorenzo Fortes, Raquel Rocha dos Santos, Genoile Oliveira Santana Silva
  Journal of Coloproctology.2021; 41(01): 096.     CrossRef
• JAK1 inhibition and inflammatory bowel disease
  Clare Harris, J R Fraser Cummings
  Rheumatology.2021; 60(Supplement): ii45.     CrossRef
• Effect of point‐of‐care gastrointestinal ultrasound on decision‐making and management in inflammatory bowel disease
  Antony B. Friedman, Anil Asthana, Simon R. Knowles, Aphra Robbins, Peter R. Gibson
  Alimentary Pharmacology & Therapeutics.2021; 54(5): 652.     CrossRef
• Factors Associated with Medication Non-Adherence in Patients with Dyslipidemia
  Eman Alefishat, Anan S. Jarab, Walid Al-Qerem, Lina Abu-Zaytoun
  Healthcare.2021; 9(7): 813.     CrossRef
• Systematic review with meta‐analysis: dietary intake in adults with inflammatory bowel disease
  Kelly Lambert, Daniel Pappas, Chiara Miglioretto, Arefeh Javadpour, Hannah Reveley, Laura Frank, Michael C. Grimm, Dorit Samocha‐Bonet, Georgina L. Hold
  Alimentary Pharmacology & Therapeutics.2021; 54(6): 742.     CrossRef
• Patients’ perspectives on medication for inflammatory bowel disease: a mixed-method systematic review
  José Diego Marques Santos, Juan Nicolás Peña-Sánchez, Sharyle A. Fowler
  European Journal of Gastroenterology & Hepatology.2021; 33(9): 1139.     CrossRef
• Adherence to treatment of patients with irritable bowel syndrome: state of the issue
  S.A. Sukhanova, A.Yu. Timakova, M.A. Livzan, M.M. Fedorin, Yu.P. Skirdenko, O.V. Gaus, K.A. Andreev, A.V. Gorbenko, M.I. Plinder
  Profilakticheskaya meditsina.2021; 24(8): 101.     CrossRef
• Adherence to Inflammatory Bowel Disease Medications in Southern New Zealand
  Kristina Aluzaite, Rhiannon Braund, Liam Seeley, Obreniokibo Ibifubara Amiesimaka, Michael Schultz
  Crohn's & Colitis 360.2021;[Epub]     CrossRef
• Impact of Demographic, Clinical and Psychosocial Variables on Drug Adherence and Outcomes in Indian Patients With Inflammatory Bowel Disease
  Rupa Banerjee, Partha Pal, Bhargavi Adigopula, Duvvuru Nageshwar Reddy
  Journal of Clinical Gastroenterology.2021; 55(10): e92.     CrossRef
• Living with Ulcerative Colitis in Japan: Biologic Persistence and Health-Care Resource Use
  Danielle Bargo, Theo Tritton, Joseph C. Cappelleri, Marco DiBonaventura, Timothy W. Smith, Takanori Tsuchiya, Sean Gardiner, Irene Modesto, Tim Holbrook, Daniel Bluff, Taku Kobayashi
  Inflammatory Intestinal Diseases.2021; 6(4): 186.     CrossRef
• Impact of pain associated with the subcutaneous administration of adalimumab
  Cristina Gely, Laura Marín, Jordi Gordillo, Míriam Mañosa, Federico Bertoletti, Fiorella Cañete, Carlos González-Muñoza, Margalida Calafat, Eugeni Domènech, Esther Garcia-Planella
  Gastroenterología y Hepatología.2020; 43(1): 9.     CrossRef
• Patient Perspectives on Short-Course Pharmacotherapy: Barriers and Facilitators to Medication Adherence
  LeeAnne B Sherwin, Diana Ross, Michelle Matteson-Kome, Matthew Bechtold, Chelsea Deroche, Bonnie Wakefield
  Journal of Patient Experience.2020; 7(5): 726.     CrossRef
• Pregnant women with IBD are more likely to be adherent to biologic therapies than other medications
  Sangmin Lee, Cynthia H. Seow, Kamala Adhikari, Amy Metcalfe
  Alimentary Pharmacology & Therapeutics.2020; 51(5): 544.     CrossRef
• Encuesta de adherencia al tratamiento en enfermedad inflamatoria intestinal. Estudio ENADEII
  Inmaculada Alonso-Abreu, Onofre Alarcón-Fernández, Marta Carrillo-Palau, Laura Ramos-López, Javier P. Gisbert, María Chaparro, Pilar Nos, Alejandro Jiménez, Enrique Quintero-Carrión
  Gastroenterología y Hepatología.2020; 43(6): 285.     CrossRef
• Impact of pain associated with the subcutaneous administration of adalimumab
  Cristina Gely, Laura Marín, Jordi Gordillo, Míriam Mañosa, Federico Bertoletti, Fiorella Cañete, Carlos González-Muñoza, Margalida Calafat, Eugeni Domènech, Esther Garcia-Planella
  Gastroenterología y Hepatología (English Edition).2020; 43(1): 9.     CrossRef
• Challenges and Approaches to Assessing Medication Adherence in Pediatric Inflammatory Bowel Diseases
  David H. Barker, Jason M. Shapiro, Debra Lobato, Elizabeth L. McQuaid, Neal S. Leleiko
  Journal of Pediatric Gastroenterology and Nutrition.2020; 70(6): 759.     CrossRef
• A 12‐month pilot study outcomes of vagus nerve stimulation in Crohn's disease
  Valérie Sinniger, Sonia Pellissier, Florence Fauvelle, Candice Trocmé, Dominique Hoffmann, Laurent Vercueil, Jean‐Luc Cracowski, Olivier David, Bruno Bonaz
  Neurogastroenterology & Motility.2020;[Epub]     CrossRef
• Survey of adherence to treatment in inflammatory bowel disease. ENADEII study
  Inmaculada Alonso-Abreu, Onofre Alarcón-Fernández, Marta Carrillo-Palau, Laura Ramos-López, Javier Pérez Gisbert, María Chaparro, Pilar Nos, Alejandro Jiménez, Enrique Quintero-Carrión
  Gastroenterología y Hepatología (English Edition).2020; 43(6): 285.     CrossRef
• Adherence to exclusive enteral nutrition by adults with active Crohn’s disease is associated with conscientiousness personality trait: a sub‐study
  C. L. Wall, A. McCombie, R. Mulder, A. S. Day, R. B. Gearry
  Journal of Human Nutrition and Dietetics.2020; 33(6): 752.     CrossRef
• Maytenus robusta Reissek, a medicinal plant popularly used to treat digestive diseases, promotes ameliorative effects in colon and liver of mice exposed to dextran sulfate sodium
  Mariéli Mees, Marianne Caroline Meurer, Luísa Nathalia Bolda Mariano, Thaise Boeing, Lincon Bordignon Somensi, Marihá Mariott, Rivaldo Niero, Valdir Cechinel-Filho, Sérgio Faloni de Andrade, Lucienir Pains Duarte, Grasiely Faria de Sousa, Priscila de Souz
  Journal of Ethnopharmacology.2020; : 113180.     CrossRef
• A Micro‐longitudinal Approach to Measuring Medication Adherence in Pediatric Inflammatory Bowel Diseases
  Jill M. Plevinsky, Lee A. Denson, Jenny Hellmann, Phillip Minar, Michael J. Rosen, Kevin A. Hommel
  Journal of Pediatric Gastroenterology and Nutrition.2020; 71(3): 366.     CrossRef
• Emulsifiers Impact Colonic Length in Mice and Emulsifier Restriction is Feasible in People with Crohn’s Disease
  Alicia M. Sandall, Selina R. Cox, James O. Lindsay, Andrew T. Gewirtz, Benoit Chassaing, Megan Rossi, Kevin Whelan
  Nutrients.2020; 12(9): 2827.     CrossRef
• Adherence to Medical Treatment in Inflammatory Bowel Disease Patients from a Referral Center in Bahia‐Brazil
  Laíla D. Andrade, Fernanda A. Oliveira, Victor D. Mariano, Monique C. A. Santos, Fernanda A. Pereira, Cláudia I. N. dos Santos, Flora M. L. Fortes, Andrea M. Pimentel, Jaciane A. Mota, Neogélia P. Almeida, Valdiana C. Surlo, Bruno C. Silva, Mila P. Pachec
  BioMed Research International.2020;[Epub]     CrossRef
• A Role for Primary Care Pharmacists in the Management of Inflammatory Bowel Disease? Lessons from Chronic Disease: A Systematic Review
  Sharmila S. Prasad, Kerith Duncanson, Simon Keely, Nicholas J. Talley, Therése Kairuz, Gerald J. Holtmann, Ayesha Shah, Marjorie M. Walker
  Pharmacy.2020; 8(4): 204.     CrossRef
• Self-assessment of treatment targets in patients with inflammatory bowel disease using a survey
  Philipp A. Reuken, Philip C. Grunert, Andreas Lügering, Niels Teich, Andreas Stallmach
  Therapeutic Advances in Gastroenterology.2020;[Epub]     CrossRef
• Longitudinal Barriers to Thiopurine Adherence in Adolescents With Inflammatory Bowel Diseases
  Jill M Plevinsky, Andrea A Wojtowicz, Steven A Miller, Rachel N Greenley
  Journal of Pediatric Psychology.2019; 44(1): 52.     CrossRef
• Adherence to Asacol once daily versus divided regimen for maintenance therapy in ulcerative colitis: a prospective, multicenter, randomized study
  Soo-Kyung Park, Sang Hyun Park, Chang Soo Eun, Geom Seog Seo, Jong Pil Im, Tae Oh Kim, Dong-Il Park
  Intestinal Research.2019; 17(3): 349.     CrossRef
• Nurse and Patient Perceptions and Preferences for Subcutaneous Autoinjectors for Inflammatory Joint or Bowel Disease: Findings from a European Survey
  Steve Fenwick, Kunal Thakur, Duncan Munro
  Rheumatology and Therapy.2019; 6(2): 195.     CrossRef
• Factors Associated with Adherence to Allergen Specific Subcutaneous Immunotherapy
  Ji-Ho Lee, So-Hee Lee, Ga-Young Ban, Young-Min Ye, Dong-Ho Nahm, Hae-Sim Park, Yoo Seob Shin
  Yonsei Medical Journal.2019; 60(6): 570.     CrossRef
• Self-Management Through Social Support Among Emerging Adults With Inflammatory Bowel Disease
  Kendra J. Kamp, Zhehui Luo, Amanda Holmstrom, Barbara Given, Gwen Wyatt
  Nursing Research.2019; 68(4): 285.     CrossRef
• Innovations in Oral Therapies for Inflammatory Bowel Disease
  Christopher Ma, Robert Battat, Parambir S. Dulai, Claire E. Parker, William J. Sandborn, Brian G. Feagan, Vipul Jairath
  Drugs.2019; 79(12): 1321.     CrossRef
• Longitudinal non‐adherence predicts treatment escalation in paediatric ulcerative colitis
  Julia K. Carmody, Jill Plevinsky, James L. Peugh, Lee A. Denson, Jeffrey S. Hyams, Debra Lobato, Neal S. LeLeiko, Kevin A. Hommel
  Alimentary Pharmacology & Therapeutics.2019; 50(8): 911.     CrossRef
• The Development of a Screening Tool to Identify and Classify Nonadherence in Inflammatory Bowel Disease
  Aria Zand, Audrey Nguyen, Zack Stokes, Welmoed van Deen, Courtney Reynolds, Magdalena Dimitrova, Ariela Khandadash, Miriam Dvorsky, Jenny Sauk, Eric Esrailian, Daniel Hommes
  Crohn's & Colitis 360.2019;[Epub]     CrossRef
• British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults
  Christopher Andrew Lamb, Nicholas A Kennedy, Tim Raine, Philip Anthony Hendy, Philip J Smith, Jimmy K Limdi, Bu’Hussain Hayee, Miranda C E Lomer, Gareth C Parkes, Christian Selinger, Kevin J Barrett, R Justin Davies, Cathy Bennett, Stuart Gittens, Malcolm
  Gut.2019; 68(Suppl 3): s1.     CrossRef
• Treatment of inflammatory bowel disease via green tea polyphenols: possible application and protective approaches
  Sajid Ur Rahman, Yu Li, Yingying Huang, Lei Zhu, Shibin Feng, Jinjie Wu, Xichun Wang
  Inflammopharmacology.2018; 26(2): 319.     CrossRef
• A RARE CASE OF CROHN DISEASE COMPLICATED WITH STEROID MONOTHERAPY-RELATED RETROPHARYNGEAL ABSCESS AND INITIALLY MISINTERPRETED PYODERMA GANGRENOSUM DEVELOPMENT
  Michael Doulberis, Jörg Dähn, Jannis Kountouras, Volker Maier, Arthur Helbling, Patrick Dubach
  Gastroenterology Nursing.2018; 41(4): 347.     CrossRef
• Clinical usefulness of remote patient monitoring using e-Health technologies in patients with inflammatory bowel diseases
  Sung Noh Hong
  The Korean Journal of Internal Medicine.2018; 33(5): 876.     CrossRef
• Is Curcumin a Possibility to Treat Inflammatory Bowel Diseases?
  Rafaela Mazieiro, Renata Reis Frizon, Sandra Maria Barbalho, Ricardo de Alvares Goulart
  Journal of Medicinal Food.2018; 21(11): 1077.     CrossRef
• Brazilian green propolis hydroalcoholic extract reduces colon damages caused by dextran sulfate sodium-induced colitis in mice
  Luisa Nathália Bolda Mariano, Caroline Arruda, Lincon Bordignon Somensi, Ana Paula Michels Costa, Eduardo Gnoatto Perondi, Thaise Boeing, Marihá Mariott, Rita de Cássia Melo Vilhena de Andr da Silva, Priscila de Souza, Jairo Kenupp Bastos, Sérgio Faloni d
  Inflammopharmacology.2018; 26(5): 1283.     CrossRef
• Medication non-adherence in inflammatory bowel diseases is associated with disability
  Jonathan Perry, Andy Chen, Viraj Kariyawasam, Glen Collins, Chee Choong, Wei Ling Teh, Nikola Mitrev, Friedbert Kohler, Rupert Wing Loong Leong
  Intestinal Research.2018; 16(4): 571.     CrossRef
• Adherence to therapy of patients with inflammatory bowel diseases
  A I Parfenov, A V Kagramanova, A F Babayan, O V Knyazev
  Terapevticheskii arkhiv.2018; 90(12): 4.     CrossRef